Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross L Prentice

Showing results (111-120 of 263) with videos related to

Pageof 27
Sort By:
JNCI Cancer Spectrum|January 4, 2021
Protein Intake by Source and Breast Cancer Incidence and Mortality: The Women's Health InitiativeKathy Pan, Joseph C Larson, Ross L Prentice, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancerRoss L Prentice, Ying Huang, David A Hinds, et al.
Cancer|June 4, 2015
Estrogen and colorectal cancer incidence and mortalitySayeh Lavasani, Rowan T Chlebowski, Ross L Prentice, et al.
Menopause (New York, N.Y.)|July 12, 2017
Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational StudyCarolyn J Crandall, Kathleen M Hovey, Christopher Andrews, et al.
American Journal of Epidemiology|July 22, 2005
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trialRoss L Prentice, Robert Langer, Marcia L Stefanick, et al.
Menopause (New York, N.Y.)|October 18, 2016
Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trialRowan T Chlebowski, Wendy Barrington, Aaron K Aragaki, et al.
American Journal of Epidemiology|September 26, 2013
Regression calibration in nutritional epidemiology: example of fat density and total energy in relationship to postmenopausal breast cancerRoss L Prentice, Mary Pettinger, Lesley F Tinker, et al.
The American Journal of Clinical Nutrition|February 21, 2014
Biomarker-calibrated protein intake and bone health in the Women's Health Initiative clinical trials and observational studyJeannette M Beasley, Andrea Z LaCroix, Joseph C Larson, et al.
Journal of the American Geriatrics Society|November 14, 2013
Biomarker-calibrated protein intake and physical function in the Women's Health InitiativeJeannette M Beasley, Betsy C Wertheim, Andrea Z LaCroix, et al.
The British Journal of Nutrition|July 20, 2017
Branched-chain amino acid, meat intake and risk of type 2 diabetes in the Women's Health InitiativeMasoud Isanejad, Andrea Z LaCroix, Cynthia A Thomson, et al.
Pageof 27

Showing results (111-120 of 263) with videos related to

Sort By:
Pageof 27
JNCI Cancer Spectrum|January 4, 2021
Protein Intake by Source and Breast Cancer Incidence and Mortality: The Women's Health InitiativeKathy Pan, Joseph C Larson, Ross L Prentice, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancerRoss L Prentice, Ying Huang, David A Hinds, et al.
Cancer|June 4, 2015
Estrogen and colorectal cancer incidence and mortalitySayeh Lavasani, Rowan T Chlebowski, Ross L Prentice, et al.
Menopause (New York, N.Y.)|July 12, 2017
Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational StudyCarolyn J Crandall, Kathleen M Hovey, Christopher Andrews, et al.
American Journal of Epidemiology|July 22, 2005
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trialRoss L Prentice, Robert Langer, Marcia L Stefanick, et al.
Menopause (New York, N.Y.)|October 18, 2016
Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trialRowan T Chlebowski, Wendy Barrington, Aaron K Aragaki, et al.
American Journal of Epidemiology|September 26, 2013
Regression calibration in nutritional epidemiology: example of fat density and total energy in relationship to postmenopausal breast cancerRoss L Prentice, Mary Pettinger, Lesley F Tinker, et al.
The American Journal of Clinical Nutrition|February 21, 2014
Biomarker-calibrated protein intake and bone health in the Women's Health Initiative clinical trials and observational studyJeannette M Beasley, Andrea Z LaCroix, Joseph C Larson, et al.
Journal of the American Geriatrics Society|November 14, 2013
Biomarker-calibrated protein intake and physical function in the Women's Health InitiativeJeannette M Beasley, Betsy C Wertheim, Andrea Z LaCroix, et al.
The British Journal of Nutrition|July 20, 2017
Branched-chain amino acid, meat intake and risk of type 2 diabetes in the Women's Health InitiativeMasoud Isanejad, Andrea Z LaCroix, Cynthia A Thomson, et al.
Pageof 27